An aortic insufficiency diagnosed under cabergoline;Une insuffisance aortique diagnostiquée sous cabergoline

Annales de Cardiologie et d'Angeiologie

Volumn 58, Issue 3, 2009, Pages 189-191

  Chague F ^a   Belleville, I ^a   Boujon, B ^a   Petit, J M ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Cabergoline; Dopamine agonists; Hyperprolactinemia; Valvulopathy

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DEXFENFLURAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FENFLURAMINE;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; LOW DRUG DOSE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; VALVULAR HEART DISEASE;

AORTIC VALVE INSUFFICIENCY; ERGOLINES; FEMALE; HUMANS; HYPERPROLACTINEMIA; MIDDLE AGED;

EID: 67349087248     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2008.05.022     Document Type: Article

References (10)

1. Schade R., Andersohn F., Suissa S., Haverkamp W., and Garbe E. Dopamine agonists and the risk of cardiac-valve regurguitation. N Engl J Med 356 (2007) 29-38
2. Zanettini R., Antonini A., Gatto G., Gentile R., Tesei S., and Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 356 (2007) 39-46
3. Roth B.L. Drugs and valvular heart disease. N Engl J Med 356 (2007) 6-9
4. Serratrice J., Disdier P., Habib G., Viallet F., and Weiller P.J. Fibrotic valvular heart disease subsequent to bromocriptine treatment. Cardiol Rev 10 (2002) 334-336
5. Corvol J.C., Schupbach M., and Bonnet A.M. Valvulopathie sous pergolide : revue critique de la littérature et conduite à tenir en pratique. Rev Neurol 161 (2005) 637-643
6. Van Camp G.V., Flamez A., Cosyns B., et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 363 (2004) 1179-1183
7. Yamamoto M., Uesugi T., and Nakayama T. Dopamine agonists and cardiac valvulopathy in Parkinson disease. Neurology 67 (2006) 1225-1229
8. Junghanns S., Fuhrmann J.T., Simonis G., Oelwein C., Koch R., and Strasser R.H. Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. Mov Disord 22 (2007) 234-238
9. Waller E.A., Kaplan J., and Heckman M.G. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 80 (2005) 1016-1020
10. Shivelly B.K., Roldan C.A., Gill E.A., Najarian T., and Loar S.B. Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine. Circulation 100 (1999) 21-27